Switching biological disease-modifying antirheumatic drugs and Janus kinase inhibitors in patients with rheumatoid arthritis
The goal of treatment of rheumatoid arthritis (RA) is to achieve remission or low disease activity. A wide range of disease-modifying antirheumatic drugs is used for the treatment of RA, including biological disease-modifying antirheumatic drugs (bDMARDs) and Janus kinase inhibitors (JAKi). However,...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
IMA-PRESS LLC
2023-07-01
|
| coleção: | Современная ревматология |
| Assuntos: | |
| Acesso em linha: | https://mrj.ima-press.net/mrj/article/view/1436 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|